---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-073431"
form_type: "8-K"
ticker: "SGMT"
cik: "0001400118"
company_name: "Sagimet Biosciences Inc."
filed_at: "2026-06-12T20:06:12+00:00"
generated_at: "2026-06-12T20:19:07.817723+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Sagimet director Tim Walbert resigns; annual meeting ratifies board and auditor

## Summary
- Tim Walbert resigned from Board effective June 12, 2026, citing other commitments, no disagreement.
- All four Class III directors elected: Jarrett, Phillips, Happel, Kemble with 6.5M-8.8M votes for each.
- KPMG LLP ratified as independent auditor for FY 2026: 19.1M for, 14k against.
- Outstanding shares of Series A common stock: 32,017,613 as of record date April 17, 2026.

## SEC filing metadata
- accession: 0001104659-26-073431
- form_type: 8-K
- ticker: SGMT
- cik: 0001400118
- company_name: Sagimet Biosciences Inc.
- filed_at: 2026-06-12T20:06:12+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1400118/000110465926073431/0001104659-26-073431-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1400118/000110465926073431/tm2617560d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-073431
- JSON: https://secwatch.observer/filing/0001104659-26-073431.json
- Plain text: https://secwatch.observer/filing/0001104659-26-073431.txt

## Key facts
- Executive change
  Tim Walbert resigned as Board Member at Sagimet Biosciences Inc..
  - Action: resigned
  - Role: Board Member
  source text: On June 12, 2026, Tim Walbert, a member of the Board of Directors (the “Board”) of Sagimet Biosciences Inc. (the “Company”), tendered his resignation from the Board, effective as of June 12, 2026.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1400118/000110465926073431/0001104659-26-073431-index.htm
- Shareholder Votes
  Sagimet Biosciences Inc. shareholders approved Election of Class III Directors at the 2026-06-12 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2026-06-12
  source text: Each of Jennifer Jarrett, Anne Phillips, M.D., David Happel and George Kemble, Ph.D. were elected to the Board to serve as Class III directors until the 2029 Annual Meeting of Stockholders and until their successors, if any, are elected or appointed, or their earlier death, resignation, retirement, disqualification or removal, as follows: Name For Withheld Broker Non-Votes Jennifer Jarrett 6,461,429 2,555,268 10,124,106 Anne Phillips, M.D. 7,806,504 1,210,193 10,124,106 David Happel 8,753,884 262,813 10,124,106 George Kemble, Ph.D. 8,688,684 328,013 10,124,106
  evidence_url: https://www.sec.gov/Archives/edgar/data/1400118/000110465926073431/0001104659-26-073431-index.htm
- Shareholder Votes
  Sagimet Biosciences Inc. shareholders approved Ratification of Independent Registered Public Accountant at the 2026-06-12 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2026-06-12
  source text: Proposal 2 - Ratification of Independent Registered Public Accountant . The appointment of KPMG LLP as the Company’s independent registered public accounting firm for the 2026 fiscal year was ratified, as follows: For Against Abstentions Broker Non-Votes 19,091,619 13,960 35,224 0
  evidence_url: https://www.sec.gov/Archives/edgar/data/1400118/000110465926073431/0001104659-26-073431-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.